X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NOVARTIS DR. DATSONS LABS/
NOVARTIS
 
P/E (TTM) x -10.9 392.8 - View Chart
P/BV x 0.2 19.3 0.8% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 DR. DATSONS LABS   NOVARTIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NOVARTIS
Mar-16
DR. DATSONS LABS/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs126982 12.8%   
Low Rs31556 5.6%   
Sales per share (Unadj.) Rs133.0252.9 52.6%  
Earnings per share (Unadj.) Rs0.262.1 0.2%  
Cash flow per share (Unadj.) Rs6.663.3 10.4%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs128.8363.6 35.4%  
Shares outstanding (eoy) m31.6631.96 99.1%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.0 19.3%   
Avg P/E ratio x516.112.4 4,170.3%  
P/CF ratio (eoy) x11.812.2 97.5%  
Price / Book Value ratio x0.62.1 28.7%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m2,47724,580 10.1%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m561,801 3.1%   
Avg. sales/employee Rs ThNM10,748.9-  
Avg. wages/employee Rs ThNM2,395.2-  
Avg. net profit/employee Rs ThNM2,641.1-  
INCOME DATA
Net Sales Rs m4,2118,083 52.1%  
Other income Rs m79829 9.5%   
Total revenues Rs m4,2898,913 48.1%   
Gross profit Rs m569234 242.8%  
Depreciation Rs m20437 556.9%   
Interest Rs m4302 23,900.0%   
Profit before tax Rs m131,025 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-217 -10.8%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m6752 0.8%   
Profit after tax Rs m51,986 0.2%  
Gross profit margin %13.52.9 466.1%  
Effective tax rate %48.073.4 65.5%   
Net profit margin %0.124.6 0.5%  
BALANCE SHEET DATA
Current assets Rs m6,85212,678 54.0%   
Current liabilities Rs m6,7112,433 275.8%   
Net working cap to sales %3.3126.7 2.6%  
Current ratio x1.05.2 19.6%  
Inventory Days Days16133 492.0%  
Debtors Days Days31822 1,416.2%  
Net fixed assets Rs m3,67369 5,307.8%   
Share capital Rs m317160 198.1%   
"Free" reserves Rs m3,76111,460 32.8%   
Net worth Rs m4,07811,621 35.1%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63314,400 87.7%  
Interest coverage x1.0570.5 0.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.6 59.4%   
Return on assets %3.413.8 24.9%  
Return on equity %0.117.1 0.7%  
Return on capital %7.723.6 32.5%  
Exports to sales %22.90.7 3,074.2%   
Imports to sales %14.318.6 76.9%   
Exports (fob) Rs m96460 1,601.3%   
Imports (cif) Rs m6021,503 40.1%   
Fx inflow Rs m964186 517.4%   
Fx outflow Rs m6071,821 33.3%   
Net fx Rs m357-1,635 -21.8%   
CASH FLOW
From Operations Rs m1,3452,531 53.1%  
From Investments Rs m-2,256-8,270 27.3%  
From Financial Activity Rs m-1,200-386 311.1%  
Net Cashflow Rs m-2,111-6,125 34.5%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 1.4 1.6 84.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 21.5 437.7%  
Shareholders   20,807 41,647 50.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   NATCO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  PLETHICO PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS